An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants
Clinical trial NCT03526978 · COMPLETED
Trial details
- NCT number
- NCT03526978
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-08
- Primary completion
- 2017-10-18
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.